Clinical Trials Logo
  1. Home
  2. Hemorrhage, Postpartum
  3. NCT03233607

Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery — QUOTABL  

Hemorrhage, Postpartum Clinical Trial

Official title:
Optimal Time for Postpartum Hemoglobin Assessment and Its Correlation With Estimated Blood Loss (EBL)/Quantitative Blood Loss (QBL)

Clinical Trial Summary

This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood loss (EBL) and quantitative blood loss (QBL).

Clinical Trial Description

Postpartum hemorrhage is a leading cause of maternal mortality and morbidity worldwide. Early intervention is dependent on care providers ability to accurately estimate ongoing blood loss. Studies in the past have shown that obstetricians and midwives tend to overestimate blood loss when the lost volumes are small while tend to underestimate by as much as 40 to 50 percent when a large volume of blood is lost.

Multiple studies have shown that routine hemoglobin assessment in postpartum patients after uneventful delivery either vaginal or via cesarean section, is not necessary. This leads to increased cost of care without any added benefit and causes inconvenience to the patients. However knowing how imprecise blood loss estimation can be it is reasonable to screen women for anemia prior to discharge. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03233607
Study type Observational
Source Columbia University
Contact
Status Completed
Phase
Start date March 20, 2018
Completion date April 23, 2019
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03723031 - Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section Phase 2
Completed NCT04370639 - A Pilot Study to Assess the Feasibility and Tolerability of the AccuFlow Perfusion Sensor for Intrapartum Hemorrhage N/A
Completed NCT03912545 - Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge
Not yet recruiting NCT06452355 - Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage N/A
Recruiting NCT05811676 - Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa Phase 3
Active, not recruiting NCT00928863 - Haemorrhagia Postpartum: an Implementation Study on the NVOG Guidelines and MOET Instructions N/A
Recruiting NCT04671680 - CNAP vs IABP in Pregnant Women With Placenta Accreta
Completed NCT05203016 - Complications Associated With Intraoperative Hypothermia.
Completed NCT03151070 - Scaling Up an Integrated Approach to Improve Delivery Care in North Guatemala With Stepped Wedge Design N/A